학술논문
Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive gastric cancer: a dose-expansion, phase 1 study
Document Type
Article
Author
Source
In The Lancet Oncology June 2019 20(6):827-836
Subject
Language
ISSN
1470-2045